Topic | Presenter | Time |
Coffee/Tea | 8.30am | |
Welcome to Biogen | Heiko Runz | 9.00am |
Welcome and review of meeting objectives | Karina Bienfait/Peter Shaw | 9.05am |
I-PWG Member introductions/Ice breaker | All | 9.15am |
Review of I-PWG recent successes and activities/Housekeeping notes | Karina Bienfait/Peter Shaw/Charlie Paulding/Julian Arbuckle | 10.15am |
Coffee/Tea | 10.30am | |
Introduction to the “Return of Results” Workshop | Nicole Hartman/ROR LDWG | 10.45am |
Session 1 – “Return of Results” Workshop | ROR LDWG | 11.00am |
Summary/Next steps for I-PWG ROR activity | Nicole Hartman/ROR LDWG | 12.30pm |
Lunch | 12.45pm | |
Session 2 – Review of current I-PWG activity and plans for 2023 – Overview of current Task Force/Working Group activity Discuss: – What other activities the I-PWG should be focusing on for 2023 (and beyond)? – Review current I-PWG working practices (what’s working well/not working well)? – What other external groups should the I-PWG be interacting with? – Discuss growth plans for the I-PWG/Other company participation/networking – Other |
Karina Bienfait/Peter Shaw/Charlie Paulding/Julian Arbuckle | 1.45pm |
Tea/Coffee | 3.15pm | |
Summary of key themes from Session 2 | Karina Bienfait/Peter Shaw/Charlie Paulding/Julian Arbuckle | 3.30pm |
ECTF demo of the new I-PWG website | Laury Mignon/Julian Arbuckle | 4.00pm |
Co-Chair transition plans 2023 | Karina Bienfait/Peter Shaw/Charlie Paulding | 4.15pm |
Meeting wrap-up/Summary | Karina Bienfait/Peter Shaw/Charlie Paulding/Julian Arbuckle | 4.30pm |
Meeting closes | 4.45pm |
Topic | Presenter | Time |
1) “The Geisinger-Regeneron DiscovEHR Collaboration: Applications of Large-Scale Genomic Analysis in a Large Clinical Population | David Carey (Geisinger) | 30 Minutes (Plus 10 mins Q & A) |
2) NIH RFI regarding “Consent wording for data and biospecimen sharing” draft response | Devon Kelley (CRISPR Therapeutics) | 10 Minutes |
3) Update on progress of the I-PWG survey team for WGS in clinical trials | Rob Power (BioMarin) | 10 Minutes |
4) MHRA Pharmacogenomics Research Workshop | Kiera Mehigan (MHRA) | 10 Minutes |
5) Status on website update | Julian Arbuckle | 5 Minutes |
6) Membership invoice status | Julian Arbuckle | 5 Minutes |
7) Next Monthly Meeting Speaker: “Return of Results Pilot Study” – Delphine Lagarde (Roche) | Peter Shaw | 5 Minutes |
8) AOB | All |
Topic | Presenter | Time |
1) “Phenome-wide collapsing analysis of rare variation in UK Biobank exomes” | Keren Carss (AstraZeneca) | 30 Minutes (Plus, Q & A) |
2) Company Spotlight – UCB | Martin Armstrong | 5 Minutes |
3) Vendor Writing Group Award | Karina Bienfait/Peter Shaw/Julian Arbuckle | 10 Minutes |
4) SCOPE Meeting Feedback | Karina Bienfait/Melissa Rawley-Payne | 10 Minutes |
5) Return of Results Survey (IRB/REC/EC) Status | Jen Ribeiro/Julian Arbuckle | 5 Minutes |
6) April Monthly Meeting Speaker: “Overview of the SCALLOP Consortium (Systematic and Combined AnaLysis of Olink Proteins)” – Anders Malarstig (Pfizer) | Karina Bienfait/Peter Shaw | 5 Minutes |
7) AOB | All | 5 Minutes |
Topic | Presenter | Time |
1) “Deep Learning and Next Generation Sequencing, An Overview and Deep Dive” | Dawer Jamshed (Vertex Labs) | 30 Minutes (plus 10 mins Q & A) |
2) Company Spotlight (Biogen) | Adele Mitchell | 5 Minutes |
3) PGx Perspectives Paper – Status | Charlie Paulding (Regeneron) | 10 Minutes |
4) Update from Education & Communication Task Force regarding plans for the review of current education materials | Jen Ribeiro/Julian Arbuckle/Laury Mignon (Ionis) | 10 Minutes |
5) March Monthly Meeting Speaker: Keren Carss – “An update of AstraZeneca’s activities around the UK Biobank exome analysis” | Karina Bienfait / Peter Shaw | 5 Minutes |
6) AOB | All | 5 Minutes |
Topic | Presenter | Time |
1) Review of the results from the “I-PWG Monthly Meeting 2020 Speaker” Survey – Planning discussion for the 2021 Monthly Meeting Speaker plans | Karina Bienfait/Peter Shaw/Jean-Claude Marshall | 30 Minutes |
2) Company Spotlight (Pfizer) | Charlie Paulding | 5 Minutes |
3) Task Force Goals for 2021 – ADME – Education & Communication – Regulatory – Consent Structure Working Group | Jean-Claude Marshall/Jen Ribeiro/Melissa Rawley-Payne/Lea Harty | 20 Minutes |
4) Future Speaker Plans – Membership request for information (see attached papers) | Karina Bienfait/Peter Shaw/Jean-Claude Marshall | 10 Minutes |
6) AOB | All | 5 Minutes |